Journal
PHARMACOGENOMICS
Volume 13, Issue 8, Pages 901-915Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.12.72
Keywords
de nova assembly; genomics; next-generation sequencing; whole-genome shotgun
Categories
Funding
- Wellcome Trust
Ask authors/readers for more resources
The next-generation sequencing (NGS) revolution has drastically reduced time and cost requirements for sequencing of large genomes, and also qualitatively changed the problem of assembly. This article reviews the state of the art in de novo genome assembly, paying particular attention to mammalian-sized genomes. The strengths and weaknesses of the main sequencing platforms are highlighted, leading to a discussion of assembly and the new challenges associated with NGS data. Current approaches to assembly are outlined and the various software packages available are introduced and compared. The question of whether quality assemblies can be produced using short-read NGS data alone, or whether it must be combined with more expensive sequencing techniques, is considered. Prospects for future assemblers and tests of assembly performance are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available